Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Kenvue
KVUE
|
+$344M |
| 2 |
JPMorgan Chase
JPM
|
+$161M |
| 3 |
Extra Space Storage
EXR
|
+$134M |
| 4 |
GE HealthCare
GEHC
|
+$113M |
| 5 |
Ferguson
FERG
|
+$97.1M |
Top Sells
| 1 |
PDCE
PDC Energy, Inc.
PDCE
|
+$313M |
| 2 |
Super Micro Computer
SMCI
|
+$305M |
| 3 |
UNVR
Univar Solutions Inc.
UNVR
|
+$176M |
| 4 |
LSI
Life Storage, Inc.
LSI
|
+$160M |
| 5 |
Walmart
WMT
|
+$112M |
Sector Composition
| 1 | Technology | 17.36% |
| 2 | Financials | 16.12% |
| 3 | Industrials | 12.99% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Healthcare | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
JBIO
3151
Jade Biosciences, Inc. Common Stock
JBIO
$244M
| $279K | ﹤0.01% |
587
-128
| -18% | -$60.8K |
|
|
EXTO
3152
DELISTED
Almacenes Exito S.A. American Depositary Share, each representing eight (8) Common Shares
EXTO
| $278K | ﹤0.01% |
+50,708
| New | +$278K |
|
3153
Sana Biotechnology
SANA
$767M
| $278K | ﹤0.01% |
71,596
+44
| +0.1% | +$171 |
|
3154
Atea Pharmaceuticals
AVIR
$258M
| $277K | ﹤0.01% |
92,351
| – | – |
|
3155
Lake Shore Bancorp
LSBK
$102M
| $276K | ﹤0.01% |
26,938
+4
| +0% | +$41 |
|
|
ICVX
3156
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $272K | ﹤0.01% |
35,129
+25,020
| +248% | +$194K |
|
3157
Smart Sand
SND
$76.7M
| $272K | ﹤0.01% |
117,238
+76,320
| +187% | +$177K |
|
3158
First Guaranty Bancshares
FGBI
$129M
| $269K | ﹤0.01% |
24,492
-661
| -3% | -$7.27K |
|
3159
Milestone Pharmaceuticals
MIST
$146M
| $269K | ﹤0.01% |
86,839
-93,148
| -52% | -$289K |
|
3160
Traeger
COOK
$188M
| $269K | ﹤0.01% |
98,484
-6,462
| -6% | -$17.6K |
|
3161
Natural Health Trends
NHTC
$53.2M
| $265K | ﹤0.01% |
49,554
-1,179
| -2% | -$6.31K |
|
3162
Biote Corp
BTMD
$109M
| $264K | ﹤0.01% |
+51,489
| New | +$264K |
|
|
GRTS
3163
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $263K | ﹤0.01% |
153,100
-51,368
| -25% | -$88.3K |
|
3164
Personalis
PSNL
$472M
| $263K | ﹤0.01% |
217,338
-111,155
| -34% | -$134K |
|
3165
HF Foods Group
HFFG
$168M
| $260K | ﹤0.01% |
65,606
| – | – |
|
3166
Zevra Therapeutics
ZVRA
$468M
| $260K | ﹤0.01% |
53,890
+8
| +0% | +$39 |
|
3167
Gray Media, Inc. Class A
GTN.A
$1.02B
| $259K | ﹤0.01% |
34,467
-16,402
| -32% | -$123K |
|
3168
ReposiTrak
TRAK
$318M
| $259K | ﹤0.01% |
29,517
+4
| +0% | +$35 |
|
|
MRNS
3169
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $258K | ﹤0.01% |
32,089
| – | – |
|
3170
Grab
GRAB
$21.6B
| $257K | ﹤0.01% |
72,701
-117,311
| -62% | -$415K |
|
3171
Telos
TLS
$464M
| $256K | ﹤0.01% |
107,236
-16,804
| -14% | -$40.2K |
|
3172
American Coastal Insurance
ACIC
$550M
| $256K | ﹤0.01% |
34,750
+11,234
| +48% | +$82.7K |
|
|
ABCM
3173
DELISTED
Abcam plc American Depositary Shares
ABCM
| $256K | ﹤0.01% |
11,301
| – | – |
|
3174
SWK Holdings
SWKH
$177M
| $255K | ﹤0.01% |
20,466
-7
| -0% | -$87 |
|
3175
Sandstorm Gold
SAND
$3.37B
| $255K | ﹤0.01% |
54,512
-17,313
| -24% | -$80.9K |
|